Literature DB >> 23548817

Clinician-identified depression in community settings: concordance with structured-interview diagnoses.

Ramin Mojtabai1.   

Abstract

BACKGROUND: Relatively little is known about the prevalence and correlates of overdiagnosis of depression in community settings. This study examined the extent to which individuals with clinician-identified depression in the community meet the criteria for DSM-IV major depressive episodes (MDE) and characteristics of these individuals.
METHODS: In a sample of 5,639 participants with clinician-identified depression drawn from the 2009-2010 United States National Survey of Drug Use and Health, the proportion of participants who met the 12-month MDE criteria, ascertained by a structured interview, and variations in MDE diagnosis across different groups of participants were examined. Mental health profiles and service use of participants who met the MDE criteria were compared to those who did not meet these criteria.
RESULTS: Only 38.4% of participants with 12-month clinician-identified depression met the 12-month MDE criteria. Older adults were less likely than younger adults to meet the criteria - only 14.3% of those 65 years old or older met the criteria, whereas participants with more education and those with poorer overall health were more likely to meet the criteria. Participants who did not meet the 12-month MDE criteria reported less distress and impairment in role functioning and used fewer services. A majority of both groups, however, were prescribed and used psychiatric medications.
CONCLUSIONS: Depression overdiagnosis and overtreatment is common in community settings in the USA. There is a need for improved targeting of diagnosis and treatments of depression and other mental disorders in these settings.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23548817     DOI: 10.1159/000345968

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  18 in total

1.  The Impact of Systematic Depression Screening in Primary Care on Depression Identification and Treatment in a Large Health Care System: A Cohort Study.

Authors:  Elizabeth R Pfoh; Isabel Janmey; Amit Anand; Kathryn A Martinez; Irene Katzan; Michael B Rothberg
Journal:  J Gen Intern Med       Date:  2020-06-03       Impact factor: 5.128

2.  Visits for Depression to Physician Assistants and Nurse Practitioners in the USA.

Authors:  Abiola O Keller; Roderick S Hooker; Elizabeth A Jacobs
Journal:  J Behav Health Serv Res       Date:  2018-04       Impact factor: 1.505

Review 3.  There are no randomized controlled trials that support the United States Preventive Services Task Force Guideline on screening for depression in primary care: a systematic review.

Authors:  Brett D Thombs; Roy C Ziegelstein; Michelle Roseman; Lorie A Kloda; John P A Ioannidis
Journal:  BMC Med       Date:  2014-01-28       Impact factor: 8.775

4.  The Role of Screening in Depression Diagnosis and Treatment in a Representative Sample of US Primary Care Visits.

Authors:  Hillary Samples; Elizabeth A Stuart; Brendan Saloner; Colleen L Barry; Ramin Mojtabai
Journal:  J Gen Intern Med       Date:  2019-08-06       Impact factor: 5.128

Review 5.  The mistreatment of major depressive disorder.

Authors:  Joel Paris
Journal:  Can J Psychiatry       Date:  2014-03       Impact factor: 4.356

6.  Leveraging a critical care database: selective serotonin reuptake inhibitor use prior to ICU admission is associated with increased hospital mortality.

Authors:  Marzyeh Ghassemi; John Marshall; Nakul Singh; David J Stone; Leo Anthony Celi
Journal:  Chest       Date:  2014-04       Impact factor: 9.410

7.  Antidepressants are not overprescribed for mild depression.

Authors:  Gregory E Simon; Rebecca C Rossom; Arne Beck; Beth E Waitzfelder; Karen J Coleman; Christine Stewart; Belinda Operskalski; Robert B Penfold; Susan M Shortreed
Journal:  J Clin Psychiatry       Date:  2015-12       Impact factor: 4.384

8.  The devil in the details: public health and depression.

Authors:  Andreas Vilhelmsson
Journal:  Front Public Health       Date:  2014-10-14

9.  The diagnostic accuracy of the Patient Health Questionnaire-2 (PHQ-2), Patient Health Questionnaire-8 (PHQ-8), and Patient Health Questionnaire-9 (PHQ-9) for detecting major depression: protocol for a systematic review and individual patient data meta-analyses.

Authors:  Brett D Thombs; Andrea Benedetti; Lorie A Kloda; Brooke Levis; Ioana Nicolau; Pim Cuijpers; Simon Gilbody; John P A Ioannidis; Dean McMillan; Scott B Patten; Ian Shrier; Russell J Steele; Roy C Ziegelstein
Journal:  Syst Rev       Date:  2014-10-27

10.  Minimal phenotyping yields genome-wide association signals of low specificity for major depression.

Authors:  Na Cai; Joana A Revez; Mark J Adams; Till F M Andlauer; Gerome Breen; Enda M Byrne; Toni-Kim Clarke; Andreas J Forstner; Hans J Grabe; Steven P Hamilton; Douglas F Levinson; Cathryn M Lewis; Glyn Lewis; Nicholas G Martin; Yuri Milaneschi; Ole Mors; Bertram Müller-Myhsok; Brenda W J H Penninx; Roy H Perlis; Giorgio Pistis; James B Potash; Martin Preisig; Jianxin Shi; Jordan W Smoller; Fabien Streit; Henning Tiemeier; Rudolf Uher; Sandra Van der Auwera; Alexander Viktorin; Myrna M Weissman; Kenneth S Kendler; Jonathan Flint
Journal:  Nat Genet       Date:  2020-03-30       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.